People with a personal or family history of thyroid cancer should not take semaglutide, and this may apply to retatrutide as well, pending FDA review
MEDVi: Best for Compounded GLP-1s MEDVi stands out as a top choice for compounded GLP-1s, starting at just $179 for the first month with no contracts or hidden membership fees
Do not use it after the expiry date on the pack
Patients were excluded if they had any other chronic liver disease other than MASLD/MASH including alcohol, viral, drug-induced, autoimmune, Budd-Chiari syndrome, Wilsons disease, alpha-1-antitrypsin deficiency, hereditary hemochromatosis, primary/secondary biliary cholangitis, primary sclerosing cholangitis, liver disorders in diseases classified elsewhere, and other chronic hepatitis not classified elsewhere
Recent cardiovascular outcome trials have demonstrated significant reductions in major adverse cardiovascular events in patients using these medications, making them valuable not just for weight loss but for overall cardiovascular health